AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionShepherd Financial Partners LLC
Latest Disclosed Ownership26,225 shares
Latest Disclosed Value $ 5,703,600
Shepherd Financial Partners LLC reports 0.39% increase in ownership of 4AB / AbbVie Inc.

On May 11, 2026 - Shepherd Financial Partners LLC filed a 13F-HR form disclosing ownership of 26,225 shares of AbbVie Inc. (BG:4AB) valued at $5,703,600 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 26,124 shares of AbbVie Inc.. This represents a change in shares of 0.39% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ABBVIE COM 00287Y109 26,225 101 0.39 5,704 -4.44 0.5411
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 26,124 103 0.40 5,969 -0.93 0.5531
2025-11-07 2025-09-30 13F ABBVIE COM 00287Y109 26,021 133 0.51 6,025 25.37 0.5734
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 25,888 286 1.12 4,805 -10.42 0.5079
2025-04-18 2025-03-31 13F ABBVIE COM 00287Y109 25,602 466 1.85 5,364 20.11 0.6290
2025-01-28 2024-12-31 13F ABBVIE COM 00287Y109 25,136 248 1.00 4,467 -9.12 0.5341
2024-10-28 2024-09-30 13F ABBVIE COM 00287Y109 24,888 503 2.06 4,915 17.50 0.5911
2024-08-08 2024-06-30 13F ABBVIE COM 00287Y109 24,385 208 0.86 4,182 -5.00 0.5393
2024-04-23 2024-03-31 13F ABBVIE COM 00287Y109 24,177 398 1.67 4,403 19.46 0.5763
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 23,779 175 0.74 3,685 4.78 0.5239
2023-11-08 2023-09-30 13F ABBVIE COM 00287Y109 23,604 924 4.07 3,518 15.12 0.5520
2023-08-11 2023-06-30 13F ABBVIE COM 00287Y109 22,680 1,372 6.44 3,056 -10.01 0.4739
2023-05-02 2023-03-31 13F ABBVIE COM 00287Y109 21,308 46 0.22 3,396 -1.16 0.5677
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 21,262 -141 -0.66 3,436 19.60 0.6218
2022-11-09 2022-09-30 13F ABBVIE COM 00287Y109 21,403 387 1.84 2,872 -10.78 0.5602
2022-08-15 2022-06-30 13F ABBVIE COM 00287Y109 21,016 165 0.79 3,219 -4.82 0.6267
2022-05-13 2022-03-31 13F ABBVIE COM 00287Y109 20,851 -1,631 -7.25 3,382 10.99 0.6038
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 22,482 497 2.26 3,047 28.51 0.5291
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 21,985 24 0.11 2,371 -4.16 0.4578
2021-08-16 2021-06-30 13F ABBVIE COM 00287Y109 21,961 431 2.00 2,474 6.18 0.4705
2021-05-14 2021-03-31 13F ABBVIE COM 00287Y109 21,530 890 4.31 2,330 5.29 0.5158
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 20,640 1,188 6.11 2,213 29.87 0.5047
2020-11-16 2020-09-30 13F/A-1 ABBVIE COM 00287Y109 19,452 -12,843 -39.77 1,704 -46.26 0.4008
2020-11-05 2020-09-30 13F ABBVIE COM 00287Y109 32,295 0 3,171 860,048.8202
2020-08-05 2020-06-30 13F ABBVIE COM 00287Y109 32,295 556 1.75 3,171 31.30 0.8600
2020-05-07 2020-03-31 13F ABBVIE COM 00287Y109 31,739 -29,802 -48.43 2,415 -55.70 0.8362
2020-01-31 2019-12-31 13F ABBVIE COM 00287Y109 61,541 198 0.32 5,451 17.38 1.2673
2019-11-25 2019-09-30 13F ABBVIE COM 00287Y109 61,343 30,376 98.09 4,644 106.22 1.1643
2019-08-05 2019-06-30 13F ABBVIE COM 00287Y109 30,967 0 0.00 2,252 -9.78 0.4230
2019-04-29 2019-03-31 13F ABBVIE COM 00287Y109 30,967 -190 -0.61 2,496 -13.12 0.4837
2019-02-07 2018-12-31 13F ABBVIE COM 00287Y109 31,157 -1,068 -3.31 2,873 -3.75 0.6250
2018-10-16 2018-09-30 13F ABBVIE COM 00287Y109 32,225 0 0.00 2,985 -0.53 0.6742
2018-08-01 2018-06-30 13F ABBVIE COM 00287Y109 32,225 -578 -1.76 3,001 -3.35 0.6750
2018-05-01 2018-03-31 13F ABBVIE COM 00287Y109 32,803 502 1.55 3,105 -0.64 0.7646
2018-02-14 2017-12-31 13F ABBVIE COM 00287Y109 32,301 -1,610 -4.75 3,125 1.49 0.7334
2017-11-13 2017-09-30 13F ABBVIE COM 00287Y109 33,911 -4,649 -12.06 3,079 11.16 0.7151
2017-08-14 2017-06-30 13F ABBVIE COM 00287Y109 38,560 -1,434 -3.59 2,770 6.62 0.6764
2017-05-08 2017-03-31 13F ABBVIE COM 00287Y109 39,994 584 1.48 2,598 5.65 0.6740
2017-02-17 2016-12-31 13F/A-1 ABBVIE COM 00287Y109 39,410 39,410 2,459 0.6974
2017-02-15 2016-12-31 13F ABBVIE COM 00287Y109 45,791 2,902 1.0279
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.